Clinical Trial Update: MP-AzeFlu Allergen Chamber - Onset of Action Study [Phase 4]

View source ↗

Summary

Phase 4 trial update for MP-AzeFlu allergen chamber focusing on onset of action in seasonal allergic rhinitis; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• MP-AzeFlu

Snippet

Sponsor: MEDA Pharma GmbH & Co. KG | Conditions: Seasonal Allergic Rhinitis | Phase 4 | Status: COMPLETED